1
Investors
About
Dicerna Pharmaceuticals develops RNA interference (RNAi) therapeutics that silence disease-causing genes to treat rare and common diseases.
Explore Dicerna Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.